ProtAffin AG appoints Dr Mike Bartley as Chief Development Officer

28-Sep-2011 - Austria

ProtAffin AG announced that it has appointed Dr. Mike Bartley to the Management Board as Chief Development Officer. In this role, Dr. Bartley will lead the preclinical and clinical development activities at ProtAffin.

Prior to joining ProtAffin, Dr. Bartley worked for 10 years at Pfizer Inc. in the UK as a Senior Project Leader for pre-clinical and clinical projects. He most recently led early clinical-stage projects in respiratory diseases at Pfizer, taking several anti-inflammatory candidates with novel mechanisms of action into the clinic.  Dr. Bartley studied at Imperial College London and was awarded a PhD by Queen Mary College London, before joining ICI (Zeneca, Syngenta) agrochemicals, where he led projects in many R&D areas, several of which progressed to product launch.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances